ASTRAZEN
Invest Now
Start SIP in
ASTRAZEN
Performance
- Low
- ₹9,060
- High
- ₹9,260
- 52 Week Low
- ₹6,220
- 52 Week High
- ₹10,691
- Open Price₹9,150
- Previous Close₹9,151
- Volume31,963
Investment Returns
- Over 1 Month -6.77%
- Over 3 Month + 15.99%
- Over 6 Month + 28.76%
- Over 1 Year + 32.36%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 197.1
- PEG Ratio
- -7
- Market Cap Cr
- 22,818
- P/B Ratio
- 33.6
- Average True Range
- 295.94
- EPS
- 70.02
- Dividend Yield
- 0
- MACD Signal
- 48.38
- RSI
- 51.21
- MFI
- 54.31
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹9,127.00
-23.5
(-0.26%)

-
- Bearish Moving Average 2
-
- Bullish Moving Average 14
- 20 Day
- ₹9,116.76
- 50 Day
- ₹8,890.71
- 100 Day
- ₹8,458.48
- 200 Day
- ₹7,833.37
Resistance and Support
9149
- R3 9,438.00
- R2 9,349.00
- R1 9,238.00
- S1 9,038.00
- S2 8,949.00
- S3 8,838.00
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹9,127 As on 08 July, 2025 | 20:53
The Market Cap of AstraZeneca Pharma India is ₹22817.5 Cr As on 08 July, 2025 | 20:53
The P/E ratio of AstraZeneca Pharma India is 197.1 As on 08 July, 2025 | 20:53
The PB ratio of AstraZeneca Pharma India is 33.6 As on 08 July, 2025 | 20:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.